Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2001
10/11/2001WO2001074791A1 Diazepane derivatives or salts thereof
10/11/2001WO2001074774A1 Ethylenediamine derivatives
10/11/2001WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001WO2001074344A2 Small organic molecule regulators of cell proliferation
10/11/2001WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001CA2405144A1 Ethylenediamine derivatives
10/11/2001CA2404413A1 Small organic molecule regulators of cell proliferation
10/11/2001CA2404386A1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/10/2001EP1142880A1 Benzimidazole derivatives
10/10/2001EP1142879A1 Imidazole compounds and medicinal use thereof
10/10/2001EP1140933A2 Process for preparing n6-substituted deaza-adenosine derivatives
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140919A1 1,4-disubstituted cyclohexane derivatives for the treatment of depression
10/10/2001EP1140918A1 Thrombin inhibitors
10/10/2001EP1140916A1 Heteroaryl-cyclic acetals
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140903A1 Aromatic amides
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140897A1 Protease inhibitors
10/10/2001EP1140896A1 Benzothiepin-anilide derivatives, their production and their use for antagonizing ccr-5
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140889A2 Compounds and methods for modulation of estrogen receptors
10/10/2001EP1140881A1 Antithrombotic amides
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140858A2 Arylpropenylimidazoles as farnesyl-protein transferase inhibitors
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140845A1 Susbstituted pyridine herbicides
10/10/2001EP1140839A1 Heterocyclic amides as inhibitors of factor xa
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140834A1 Heterocyclic piperidines as modulators of chemokine receptor activity
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140786A1 Reductive alkylation of secondary amines with hydrosilane
10/10/2001EP1140784A2 Ion channel modulating agents
10/10/2001EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
10/10/2001EP1140074A1 Indole and indolizidine derivatives for the treatment of migraine
10/10/2001EP1100512A4 Preparation of thioarabinofuranosyl compounds and use thereof
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0764163B1 Tachykinin (nk 1) receptor antagonists
10/10/2001EP0759907B1 Substituted 3-phenylpyrazoles for use as herbicides
10/10/2001CN1317004A Benzoyl derivatives, method for producing them and their use as herbicides and plant growth regulators
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1316991A Azetidine derivatives, preparation and medicines containing them
10/10/2001CN1316425A Photochromic diarylheterocycloethylene compounds sensitive to blue light and its preparing process and usage
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/10/2001CN1072668C Dihydrobenzofuran and related compounds useful and anti-inflammatory agents
10/10/2001CN1072663C Novel benzoyl guanidine derivatives, process for their preparation and thier use in the preparation of medicines
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300357 For therapy of mycotic disease of a human being and an animal
10/09/2001US6300342 Antithrombotic phenylalkyl derivatives
10/09/2001US6300333 Substituted piperidines, processes for their preparation and their use as pesticides and fungicides
10/09/2001US6300280 Compounds for herbicides and insecticides.
10/09/2001CA2177147C 2-oxoindoline derivative
10/09/2001CA2119662C New nitrogen bicyclic derivatives, their preparation process and pharmaceutical compositions comtaining them
10/09/2001CA2018960C Salicylaldehyde derivatives and salicylic acid derivatives and their sulfur analogs, their preparation and their use as herbicides and bioregulators
10/04/2001WO2001072745A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
10/04/2001WO2001072740A1 Substituted 1-(4-aminophenyl) triazoles and their use as anti-inflammatory agents
10/04/2001WO2001072735A2 Benzopyranes useful as tnf alpha inhibitors
10/04/2001WO2001072723A1 Oxa(thia)zolidine derivative and anti-inflammatory drug
10/04/2001WO2001072721A2 Synergistic methods and compositions for treating cancer
10/04/2001WO2001072711A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001072685A2 Polyamine analogues as cytotoxic agents
10/04/2001WO2001029245A8 ENZYMATIC PROCESS FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS
10/04/2001US20010027254 Conform stable molecular aggregates and exhibit metallic lusters; semiconductors
10/04/2001US20010027207 Modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation; anticarcinogenic, -diabetic, -proliferative and -inflammatory agents; vascular system disorders
10/04/2001US20010027196 Adenosine receptor ligands and their use in the treatment of disease
10/04/2001US20010027195 Indeno [1,2-c]pyrazol-4-ones and their uses
10/04/2001US20010027193 1-Diarylmethyl-4-alkyl or alkylsulfonylalkyl-azetidines; cannabinoid receptor antagonists; nervous system disorders (CNS); cardiovascular and glandular disorders; drug abuse; psychological disorders;
10/04/2001EP1137642A1 Bis-sulfonamides
10/04/2001EP0888304B1 Substituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same by 4-arylo-4-cyanoheptane dicarboxylic acid cyclisation, and use thereof for preparing 3-aryl-3-hydroxyalkylpiperidines
10/04/2001EP0855999B1 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
10/04/2001EP0841327B1 Triazole antifungal agent
10/04/2001EP0730581B1 3-acylaminobenzazepines
10/04/2001EP0698013B1 Fungicidal fused bicyclic pyrimidinones
10/04/2001EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/04/2001EP0563384B1 Uracil derivative
10/04/2001DE19947154A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/04/2001CA2404712A1 Synergistic methods and compositions for treating cancer comprising antiproliferative cytotoxic and cytostatic agents
10/04/2001CA2404662A1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
10/04/2001CA2403814A1 Polyamine analogues as cytotoxic agents
10/04/2001CA2401748A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
10/04/2001CA2401242A1 Pharmaceutically active pyrrolidine derivatives
10/03/2001CN1315948A Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO) polymer matrices containing them
10/03/2001CN1315873A Prevention/remedies for multiple organ failure
10/03/2001CN1315830A Treatment of anxiety disorders
10/03/2001CN1315320A Ether and amide compounds as medicide for treating glycuresis and preparing process thereof
10/03/2001CN1072221C 3-halo-3-heteroaryl carboxylic acid derivatives, method of preparing them and intermediates
10/02/2001US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene
10/02/2001US6297374 Nitroimino-nitromethylene—azole or-azine heterocyclic compounds, insecticidal compositions containing them, and insecticidal methods of using them
10/02/2001US6297269 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
10/02/2001US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure
1 ... 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 ... 523